Winfried Barchet

Winfried Barchet has a diverse work experience spanning over two decades. Winfried is currently working as the VP Immunology at OMass Therapeutics since January 2023. Before joining OMass Therapeutics, they were the Executive Director Innate Immunity at IFM Therapeutics from November 2019 to September 2022. Prior to that, they served as the Discovery Area Leader for Innate Immunity at Roche from September 2017 to October 2019.

Winfried Barchet also has extensive experience in academia. Winfried worked at The University of Bonn from 2006 to 2019, where they held various positions including DZIF research group leader and DZIF Professor of Translational Immunology. During their time at the university, they led a research team and conducted research on nucleic acid sensor agonists, secured research funding, and made significant contributions to scientific publications and patents.

Before joining The University of Bonn, they worked as a Postdoctoral Researcher at Washington University in St. Louis from 2002 to 2006. Winfried was also a Pre-doctoral Fellow at EMBL from 1998 to 2002. Winfried started their career with a Summer Internship at the Centers for Disease Control and Prevention in 1998.

Overall, Winfried Barchet's work experience showcases their expertise in immunology, innate immunity, and translational research.

Winfried Barchet's education history is as follows: From 1993 to 1995, they attended Freie Universität Berlin where they obtained a Vordiplom in Biochemistry. From 1995 to 1998, they pursued their education at ETH Zürich and completed a Diploma in Biochemistry. Finally, from 1998 to 2002, they attended the University of Cologne, where they earned a Doctor of Philosophy - PhD degree in In vivo Immunology and Genetics.